These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33582207)

  • 21. Severity of psychotic episodes in predicting concurrent depressive and anxiety features in acute phase schizophrenia.
    Naidu K; van Staden WC; van der Linde M
    BMC Psychiatry; 2014 Jun; 14():166. PubMed ID: 24903304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort.
    Fond G; Boyer L; Berna F; Godin O; Bulzacka E; Andrianarisoa M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Schürhoff F; Llorca PM;
    Br J Psychiatry; 2018 Aug; 213(2):464-470. PubMed ID: 29871707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset.
    Berna F; Misdrahi D; Boyer L; Aouizerate B; Brunel L; Capdevielle D; Chereau I; Danion JM; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Lancon C; Mallet J; Rey R; Passerieux C; Schandrin A; Schurhoff F; Tronche AM; Urbach M; Vidailhet P; Llorca PM; Fond G;
    Schizophr Res; 2015 Dec; 169(1-3):255-261. PubMed ID: 26589388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ).
    Sunhary De Verville PL; Stubbs B; Etchecopar-Etchart D; Godin O; Andrieu-Haller C; Berna F; Aouizerate B; Capdevielle D; Chereau I; Clauss-Kobayashi J; Coulon N; Dorey JM; Dubertret C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Urbach M; Llorca PM; Schürhoff F; Lançon C; Boyer L; Fond G;
    Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1273-1282. PubMed ID: 35441901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia.
    Fond G; Faugere M; Faget-Agius C; Cermolacce M; Richieri R; Boyer L; Lançon C
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):879-886. PubMed ID: 30078128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment adherence and quality of sleep in schizophrenia outpatients.
    Afonso P; Brissos S; Cañas F; Bobes J; Bernardo-Fernandez I
    Int J Psychiatry Clin Pract; 2014 Jan; 18(1):70-6. PubMed ID: 24047426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between sleep disturbance and aggressive behaviour among community-dwelling schizophrenia patients: a moderated mesomeric effect model.
    Ye Z; Wu D; Yue Y; Li T; Sun L; Yu P; Tong Y; Xiao L
    BMC Public Health; 2024 Jun; 24(1):1600. PubMed ID: 38879495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset.
    Fond G; Boyer L; Boucekine M; Aden LA; Schürhoff F; Tessier A; Andrianarisoa M; Berna F; Brunel L; Capdevielle D; Chereau I; Mallet J; Denizot H; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Rey R; Richieri R; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Misdrahi D;
    Schizophr Res; 2017 Apr; 182():84-89. PubMed ID: 27789187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schizophrenia patients with predominantly positive symptoms have more disturbed sleep-wake cycles measured by actigraphy.
    Afonso P; Brissos S; Figueira ML; Paiva T
    Psychiatry Res; 2011 Aug; 189(1):62-6. PubMed ID: 21257208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort.
    Fond G; Boyer L; Andrianarisoa M; Godin O; Bulzacka E; Berna F; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Leignier S; Mallet J; Misdrahi D; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Schurhoff F; Llorca PM;
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():62-68. PubMed ID: 29678770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reliability and validity of the Persian version of the Pittsburgh Sleep Quality Index (PSQI-P).
    Farrahi Moghaddam J; Nakhaee N; Sheibani V; Garrusi B; Amirkafi A
    Sleep Breath; 2012 Mar; 16(1):79-82. PubMed ID: 21614577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study].
    Bouhlel S; Jones Y; Khelifa E; Msolly M; Melki W; El-Hechmi Z
    Encephale; 2012 Oct; 38(5):397-403. PubMed ID: 23062453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort.
    Misdrahi D; Tessier A; Daubigney A; Meissner WG; Schurhoff F; Boyer L; Godin O; Bulzacka E; Aouizerate B; Andrianarisoa M; Berna F; Capdevielle D; Chereau-Boudet I; D'Amato T; Dubertret C; Dubreucq J; Faget-Agius C; Lançon C; Mallet J; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Fond G;
    J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30695288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms.
    Stauffer VL; Song G; Kinon BJ; Ascher-Svanum H; Chen L; Feldman PD; Conley RR
    Schizophr Res; 2012 Feb; 134(2-3):195-201. PubMed ID: 22019076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor sleep quality is associated with depressive symptoms in patients with heart disease.
    Norra C; Kummer J; Boecker M; Skobel E; Schauerte P; Wirtz M; Gauggel S; Forkmann T
    Int J Behav Med; 2012 Dec; 19(4):526-34. PubMed ID: 22125117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep Quality in Patients With Schizophrenia in a Tertiary Care Center in Northern India.
    Chaurasia N; Mishra P; Garg S; Malik G
    Prim Care Companion CNS Disord; 2023 Dec; 25(6):. PubMed ID: 38198703
    [No Abstract]   [Full Text] [Related]  

  • 37. Depressive symptoms and chronic peripheral inflammation are associated with impaired functional remission in schizophrenia independently of psychotic remission.
    Fond G; Faugere M; Richieri R; Cermolacce M; Korchia T; Micoulaud-Franchi JA; Sunhary de Verville PL; Boyer L; Lançon C
    J Affect Disord; 2021 Feb; 280(Pt A):267-271. PubMed ID: 33220563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex Difference in Comorbid Depression in First-Episode and Drug-Naive Patients With Schizophrenia: Baseline Results From the Depression in Schizophrenia in China Study.
    Li Z; Liu X; Xu H; Zhao L; Zhou Y; Wu X; Huang X; Lang X; Wu F; Zhang X
    Psychosom Med; 2021 Nov-Dec 01; 83(9):1082-1088. PubMed ID: 34419998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian functioning and quality of life in substance use disorder patients with and without comorbid schizophrenia.
    Hashemzadeh I; Navarro JF; Adan A
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110623. PubMed ID: 36029929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naïve patients with schizophrenia presenting with first episode psychosis.
    Dai J; Du X; Yin G; Zhang Y; Xia H; Li X; Cassidy R; Tong Q; Chen D; Teixeira AL; Zheng Y; Ning Y; Soares JC; He MX; Zhang XY
    Schizophr Res; 2018 Mar; 193():182-187. PubMed ID: 28651908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.